40
1 Routes of Cancer Dissemination in Metastatic Disease Maura Kennedy Harvard Medical School Year III Gillian Lieberman, M.D. Maura Kennedy November 2004 Gillian Lieberman, M.D.

Mechanism of Dissemination in Metastatic Cancer

  • Upload
    vodung

  • View
    213

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Mechanism of Dissemination in Metastatic Cancer

1

Routes of Cancer Dissemination in Metastatic Disease

Maura KennedyHarvard Medical School Year III

Gillian Lieberman, M.D.

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 2: Mechanism of Dissemination in Metastatic Cancer

2

Mechanisms of Cancer Spread

• Local Invasion– Infiltration, invasion and destruction of surrounding

tissue• Metastasis

– Lymphangitic Spread• carcinomas

– Hematagenous Spread• sarcomas

– Direct Seeding• peritoneum

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 3: Mechanism of Dissemination in Metastatic Cancer

3

Lymphangitic Spread

• Most common pathway for dissemination of carcinoma

• Follows natural route of drainage• Lymphadenopathy

– Spread and growth of cancer cells and/or– reactive hyperplasia

• Can be anterograde or retrograde

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 4: Mechanism of Dissemination in Metastatic Cancer

4

Lymphangitic Spread Patient #1

• Presented the end of 2003 with hemoptysis• 40 pack-year history of smoking• Chest Radiograph and CT

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 5: Mechanism of Dissemination in Metastatic Cancer

5

Lymphangitic Spread: Patient #1

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 6: Mechanism of Dissemination in Metastatic Cancer

6

Lymphangitic Spread: Patient #1

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 7: Mechanism of Dissemination in Metastatic Cancer

7

• Pleural lymphatics: – course over visceral pleural surface– drain into hilar nodes at medial

aspect of lung– anastamose with the parencyhmal

lymphatics• Parenchymal lymphatics:

– interlobular septal and bronchovascular bundles

– anastamose intralobular

interlobar lobar hilar nodes

• Hilar nodes drain to mediastinum

Lymphangitic Spread: Patient #1

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 8: Mechanism of Dissemination in Metastatic Cancer

8

Lymphangitic Spread: Patient #1

• RUL R paratracheal and anterior mediastinal LN

• RML and RLL subcarinal R paratracheal

and anterior mediastinal LN• LUL subaortic and

paraaortic LN• LLL subcarinal and

subaortic nodesMcLoud et al. Rad Clin N Am 1982; 20: 453-468

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 9: Mechanism of Dissemination in Metastatic Cancer

9

• Approx. 1 yr. later presents with new cough• New and enlarged lymphadenopathy

– Supraclavicular– Mediastinal– Pretracheal– Subcarinal– Hilar

Lymphangitic Spread: Patient #1

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 10: Mechanism of Dissemination in Metastatic Cancer

10Left Subclavicular LN (1.4 x 1.9 cm)

Lymphangitic Spread: Patient #1

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 11: Mechanism of Dissemination in Metastatic Cancer

11Right Subclavicular LN (1.1 x 1.4 cm)

Lymphangitic Spread: Patient #1

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 12: Mechanism of Dissemination in Metastatic Cancer

12

Right Hilar LN (1.5 x 1.5 cm)

Lymphangitic Spread: Patient #1

Left Hilar LN (2.2 x 2.2 cm)

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 13: Mechanism of Dissemination in Metastatic Cancer

13

• Focal Narrowing of L lingular bronchus due to soft tissue mass 2.0 x 2.2 cm at left hilum

Lymphangitic Spread: Patient #1

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 14: Mechanism of Dissemination in Metastatic Cancer

14

Imaging Techniques and Staging

• CT: – PPV = 0.56– NPV = 0.83

• FDG PET– PPV 0.79– NPV 0.93

Nodal Status

Definition

N0 No regional LN metastasis

N1 Ipsilateral peribronchial, hilar, or intrapulmonary LN

N2 Ipsilateral mediastinal and/or subcarinal lymph LN

N3 Contralateral mediastinal or hilar LN or to ipsilateral or contralateral supraclavicular LN

Lymphangitic Spread: Patient #1

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 15: Mechanism of Dissemination in Metastatic Cancer

15

Patient #1 – Vertebral Metastases• Additional Sx: Back Pain• CT and Bone Scan confirmed metastases to

T12 and L pubic ramus

PACS, BIDMC

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 16: Mechanism of Dissemination in Metastatic Cancer

16

• Typical metastatic route for sarcomas• Veins more readily invaded than arteries

– Portal v. invasion/its tributary liver metastases

– IVC invasion/its tributaries lung metastases– Thyroid and prostate cancer can invade

invasion paravertebral plexus lung metastases

Hematagenous Spread

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 17: Mechanism of Dissemination in Metastatic Cancer

17

Hematagenous Spread: Patient #2

• Papillary Thyroid Carcinoma– diagnosed in childhood– s/p thyroidectomy– routine surveillance for recurrence

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 18: Mechanism of Dissemination in Metastatic Cancer

18

Hematagenous Spread: Patient #2

SVC

Vascular Invasion and distant metastases:• 10-15% papillary carcinoma

•metastases to lung, bone, and mediastinum

• Up to 50% follicular carcinomas•Metastases to lung, bone, brain

Moore and Agur. Essential Clinical Anatomy 2nd

Edition. Lippincott Williams and Wilkins. 2002

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 19: Mechanism of Dissemination in Metastatic Cancer

19Courtesy J Anthony Parker, M.D., Nuclear Medicine, BIDMC

Hematagenous Spread: Patient #2

5 days s/p I131

(CT: 8 small, non-specific pulmonary nodules bilaterally, < 4 mm

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 20: Mechanism of Dissemination in Metastatic Cancer

20

• I131 imaging

• Patient with metastatic follicular thyroid carcinoma

• Multiple skeletal and pulmonary metastases.

Hematagenous Spread: Thyroid Metastases

Sherman. Lancet 2003; 361: 501-511

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 21: Mechanism of Dissemination in Metastatic Cancer

21

I131 scan: diffuse metastatic pulmonary nodulesChest radiograph: diffuse nodularity. www. Auntminnie.com

Hematagenous Spread: Thyroid Metastases

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 22: Mechanism of Dissemination in Metastatic Cancer

22

Dissemination of Ovarian Cancer• Direct Spread• Intraperitoneal Dissemination• Lymphatics• Hematagenous SpreadFIGO Staging Criteria:I: confined to ovariesII: peritoneal metastasesIII: extrapelvic peritoneal masses, abdominopelvic nodal

massesIV: metastases outside abdomen and pelvis

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 23: Mechanism of Dissemination in Metastatic Cancer

23

• Surrounding Pelvic Tissue– Fallopian Tubes– Uterus– Contralateral Ovary

• Bladder• Rectum• Pelvic Sidewall

Ovarian Cancer: Direct Extension

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 24: Mechanism of Dissemination in Metastatic Cancer

24

• Black Arrow: Irregular border between left ovary and uterus

• Curved arrow: irregular nodularity in surrounding tissues.

• Ascites

Ovarian Cancer: Direct Extension

Woodward et al. Radiographics 2004; 24 (1): 225-245

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 25: Mechanism of Dissemination in Metastatic Cancer

25

Ovarian Cancer: Intraperitoneal Dissemination

• Present in up to 70% patients undergoing staging laparotomy

• Exfoliation of malignant cells into peritoneal fluid, following natural flow of peritoneal fluid in the peritoneal cavity

• Dissemination along mesentery and ligaments

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 26: Mechanism of Dissemination in Metastatic Cancer

26

Ovarian Cancer: Intraperitoneal Dissemination

Peritoneal Fluid Circulation:

• Caudal with gravity

• Cephalad with expiration

• Fluid directed by bowel peristalsis and peritoneal reflections and mesenteries

Raptopoulos, Gourtsoyiannis Eur Radiol (2001) 11:2195-2206

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 27: Mechanism of Dissemination in Metastatic Cancer

27Raptopoulos, Gourtsoyiannis Eur Radiol (2001) 11:2195-2206

Peritoneal Fluid Collections:• L infracolic pelvis• R infracolic ileoceccal jx

(overflow to Pouch of Douglas)

Peritoneal Seeding – Main Sites• pouch of Douglas• paracolic gutters• surface of small and large bowel• greater omentum• liver surface• subphrenic space

Ovarian Cancer: Intraperitoneal Dissemination

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 28: Mechanism of Dissemination in Metastatic Cancer

28

Radiographic Signs:• plaque like or nodular peritoneal, omental, mesenteric

implants• nodularity, thickening, or enhancement of peritoneal

surfaces• bowel wall thickening or distortion• capsular liver involvement: smooth, well defined,

elliptical, biconvesx appearance.• ascites is non-specific sign, but suggestive

Ovarian Cancer: Intraperitoneal Dissemination

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 29: Mechanism of Dissemination in Metastatic Cancer

29

Coakley. Radiol Clin N Am 40 (2002) 609-636

Ovarian Cancer: Intraperitoneal Dissemination

Woodward et al. Radiographics 2004; 24 (1): 225-245

Nodularity or scalloping of liver capsule; no parenchymal invasion

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 30: Mechanism of Dissemination in Metastatic Cancer

30

Ovarian Cancer: Intraperitoneal Dissemination

Coakley/Radiol Clin N Am 40 (2002) 609-636

Peritoneal implants in left pericolic gutter

Omental cake: peritoneal implants in greater omentum

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 31: Mechanism of Dissemination in Metastatic Cancer

31Mesenteric Infilitration

Sheth et al. RadioGraphics 2003; 23: 457-473

Ovarian Cancer: Intraperitoneal Dissemination

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 32: Mechanism of Dissemination in Metastatic Cancer

32

Summary

• Local Invasion– Example: ovarian cancer

• Metastasis– Lymphangitic Spread

• Example: lung cancer– Hematagenous Spread

• Example: thyroid cancer– Direct Seeding

• Example: ovarian cancer

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 33: Mechanism of Dissemination in Metastatic Cancer

33

Summary

• Understanding mechanisms of metastatic spread of cancers can assist the radiologist– Evaluation of radiologic studies for evidence of

metastatic or recurrent disease– Assist surgeon/oncologist in cancer staging– Identify primary cancer in patient presenting

with metastatic cancer of unknown origin

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 34: Mechanism of Dissemination in Metastatic Cancer

34

Acknowledgements

Special thanks to:• Jesse Wei, M.D.• J. Anthony Parker, M.D.• Gillian Lieberman, M.D.• Pamela Lepkowski• Larry Barbaras

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 35: Mechanism of Dissemination in Metastatic Cancer

35

References• McLoud TC and Meyer JE. Mediastinal Metastases. Rad Clin N Am

1982; 20: 453-468• Chen L, Berek J. Clinical Manifestations, diagnosis, and staging of

ovarian cancer. UpToDate 2004.• Coakley FV. Staging ovarian cancer: role of imaging. Radiol Clin N.

Am, 2002; 40: 609-636• Park CM, Kim SH, Kim SH, Moon MH, Kim KW, Choi HJ.

Recurrent ovarian malignancy: patterns and spectrum of imaging findings.Raptopoulus V, Gourtsoyiannis N. Eur Radiol 2001; 11: 2195-2206.

• Sharma A et al. Patterns of Lympadenopathy in Thoracic Malignancies. Radiographics 2004; 24: 419-434

• Sherman SI. Thyroid Carcinoma. Lancet 2003; 361: 501-511

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 36: Mechanism of Dissemination in Metastatic Cancer

36

References (cont)• Sheth S, Horton KM, Garland MR, Fishman EK. Mesenteric

Neoplasms: CT Appearances of Primary and Secondary Tumors and Differential Diagnosis. Radiographics 2003; 23: 457-473.

• Woodward PJ, Hosseinzadeh K, Saenger JS. From the Archives of the AFIP Radiologic Staging of Ovarian Carcinoma with Pathologic Correlation. RadioGraphics 2004; 24: 225-246

• Intraperitoneal Spread of Malignancies. In Dynamic Radiology of the Abdomen: Normal and Pathology Anatomy, 4th Edition. Myers MA. © 1994, Springer-Verlag, NY.

• Neoplasia. In Robbins Pathologic Basis of Disease, 6th Edition. Cotran RS, Kumar V, and Collins T (ed). © 1999. W.B. Saunders Co. Philadelphia

• www.auntminnie.com. Thyroid Carcinoma

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 37: Mechanism of Dissemination in Metastatic Cancer

37

Lymphatic drainage routes:1. Along ovarian vessels

retroperitoneal paraaortic and paracaval LN

2. Laterally along broad ligament

internal iliac and obturator LN of pelvic side wall

3. Along round ligament inguinal nodes groin metastases

4. 80% peritoneal fluid drains via diaphragmatic LN LAD of anterior diaphragmatic nodes behind sternum and lateral diaphragmatic LN near phrenic nerves

Ovarian Cancer: Lymphangetic Spread

Moore and Agur. Essential Clinical Anatomy 2nd

Edition. Lippincott Williams and Wilkins. 2002

3

2

14

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 38: Mechanism of Dissemination in Metastatic Cancer

38

Ovarian Cancer: Lymphangetic Spread

Lymphatic metastases along obturator lymphatic chain

Lymph node metastases in retroperitoneum

Coakley. Radiol Clin N Am 40 (2002) 609-636

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 39: Mechanism of Dissemination in Metastatic Cancer

39

Ovarian Cancer: Hematagenous Spread

• Least common metastatic mode for ovarian cancer

• Most common site = liver– Left ovarian vein left renal vein portal

veins• 2nd most common site = lung

– Right ovarian vein IVC lung metastases

Maura Kennedy November 2004

Gillian Lieberman, M.D.

Page 40: Mechanism of Dissemination in Metastatic Cancer

40Coakley. Radiol Clin N Am 40 (2002) 609-636

Ovarian Cancer: Hematagenous Spread to Liver

Maura Kennedy November 2004

Gillian Lieberman, M.D.